• ways of using pre-clinical information more effectively to improve scientific components of clinical trials in cancer • how are these data currently utilised • how can we improve the use of these data • phase 1 and 2 clinical trials • the conventional route to drug development and how it has changed to address new challenges • phase 3 clinical trials• what you need to know and how to make it happen |
Season: | Spring |
Fees: | £ 495.00 |
Vat: | £ 86.63 |
Total fees: | £ 581.63 |